微粒体谷胱甘肽S-转移酶1(microsomal glutathione S-transferase 1,MGST1)是谷胱甘肽S-转移酶(glutathione S-transferase,GST)超家族和花生四烯酸与谷胱甘肽代谢中的膜相关蛋白(membrane-associated proteins in eicosanoid and gluta...微粒体谷胱甘肽S-转移酶1(microsomal glutathione S-transferase 1,MGST1)是谷胱甘肽S-转移酶(glutathione S-transferase,GST)超家族和花生四烯酸与谷胱甘肽代谢中的膜相关蛋白(membrane-associated proteins in eicosanoid and glutathione metabolism,MAPEG)超家族的共同成员,它通过催化外源性物质的II相解毒过程,从而保护细胞膜免受氧化应激的损伤。众多研究发现MGST1与恶性肿瘤的发生发展密切相关,有望成为癌症治疗的新型分子靶点。本文就MGST1在恶性肿瘤中的研究进展予以综述。展开更多
在Ce_(0.8)Cu_(0.2)O_(2)氧载体中添加不同质量S-1分子筛,并利用XRD、BET、XPS、SEM、TEM和CH4-TPR&CO_(2)-TPO等表征对氧载体的物化特性和反应性能进行了研究。考察了S-1分子筛添加量对Ce_(0.8)Cu_(0.2)O_(2)氧载体在化学链甲烷重...在Ce_(0.8)Cu_(0.2)O_(2)氧载体中添加不同质量S-1分子筛,并利用XRD、BET、XPS、SEM、TEM和CH4-TPR&CO_(2)-TPO等表征对氧载体的物化特性和反应性能进行了研究。考察了S-1分子筛添加量对Ce_(0.8)Cu_(0.2)O_(2)氧载体在化学链甲烷重整耦合CO_(2)还原反应中的性能的影响。与单纯的Ce_(0.8)Cu_(0.2)O_(2)氧载体相比,添加了0.3 g S-1分子筛后复合氧载体的比表面积明显增大,从15.44 m^(2)/g提高至73.27 m^(2)/g。同时热稳定性和结构稳定性也得到了很大的改善。添加了0.3 g S-1分子筛的复合氧载体CH4转化率由38.93%提升至56.03%,CO_(2)还原过程中CO产率由1.18 mmol/g增加至2.16 mmol/g。展开更多
Objective:Gemcitabine plus nab-paclitaxel(GnP)is the standard first-line therapy for advanced pancreatic ductal adenocarcinoma(PDAC).S-1,an oral fluoropyrimidine derivative,as compared with gemcitabine,is non-inferior...Objective:Gemcitabine plus nab-paclitaxel(GnP)is the standard first-line therapy for advanced pancreatic ductal adenocarcinoma(PDAC).S-1,an oral fluoropyrimidine derivative,as compared with gemcitabine,is non-inferior in terms of overall survival(OS)and is associated with lower hematologic toxicity.Accordingly,S-1 is a convenient oral alternative treatment for advanced PDAC.This study was aimed at comparing the efficacy and safety of gemcitabine plus S-1(GS)vs.GnP as first-line chemotherapy for advanced PDAC.Methods:Patients with advanced PDAC who received first-line GS or GnP at the Peking Union Medical College Hospital between March 2011 and November 2022 were evaluated.Results:A total of 300 patients were assessed,of whom 84 received GS and 216 received GnP.The chemotherapy completion rate was higher with GS than GnP(50.0%vs.30.3%,P=0.0028).The objective response rate(ORR)was slightly higher(14.3%vs.9.7%,P=0.35),and the median OS was significantly longer(17.9 months vs.13.3 months,P=0.0078),in the GS group than the GnP group.However,the median progression-free survival(PFS)did not significantly differ between groups.Leukopenia risk was significantly lower in the GS group than the GnP group(14.9%vs.28.1%,P=0.049).Conclusions:As first-line chemotherapy for advanced PDAC,the GS regimen led to a significantly longer OS than the GnP regimen.The PFS,ORR,and incidence of severe adverse events were comparable between the GS and GnP groups.展开更多
A novel composite material(TD)composed of TS-1 microcrystalline and dendritic mesoporous silica nanospheres(DMSNs)was successfully prepared.The TD composite material had open pore structure and large specific surface ...A novel composite material(TD)composed of TS-1 microcrystalline and dendritic mesoporous silica nanospheres(DMSNs)was successfully prepared.The TD composite material had open pore structure and large specific surface area,which was conducive to the mass transfer of reactants and products.The Ti element in TS-1 could be used as an electron assistant,and the spillover d-electrons were conducive to the improvement of the sulfidation and dispersion of MoS_(2),thereby forming more type II MoS_(2) active phases.The incorporation of Ti could bring more Brønsted(B)and Lewis(L)acid,which was conducive to the hydrogenation pathway(HYD)selectivity(41.2%)of dibenzothiophene(DBT)hydrodesulfurization(HDS)and isomerization(ISO)route selectivity(21.9%)of 4,6-dimethyldibenzothiophene(4,6-DMDBT)HDS,thus improve the HDS activity of DBT and 4,6-DMDBT.NiMo/TD-70(Aging temperature=70℃)had the best HDS activities of DBT(99.0%)and 4,6-DMDBT(93.7%)due to its large open pore structure,good acidity,suitable metal-support interaction(MSI)and perfect dispersion of the metallic active sites.展开更多
文摘在Ce_(0.8)Cu_(0.2)O_(2)氧载体中添加不同质量S-1分子筛,并利用XRD、BET、XPS、SEM、TEM和CH4-TPR&CO_(2)-TPO等表征对氧载体的物化特性和反应性能进行了研究。考察了S-1分子筛添加量对Ce_(0.8)Cu_(0.2)O_(2)氧载体在化学链甲烷重整耦合CO_(2)还原反应中的性能的影响。与单纯的Ce_(0.8)Cu_(0.2)O_(2)氧载体相比,添加了0.3 g S-1分子筛后复合氧载体的比表面积明显增大,从15.44 m^(2)/g提高至73.27 m^(2)/g。同时热稳定性和结构稳定性也得到了很大的改善。添加了0.3 g S-1分子筛的复合氧载体CH4转化率由38.93%提升至56.03%,CO_(2)还原过程中CO产率由1.18 mmol/g增加至2.16 mmol/g。
基金supported by grants from National High Level Hospital Clinical Research Funding(Grant Nos.2022-PUMCH-D-001 and 2022-PUMCH-A-213)。
文摘Objective:Gemcitabine plus nab-paclitaxel(GnP)is the standard first-line therapy for advanced pancreatic ductal adenocarcinoma(PDAC).S-1,an oral fluoropyrimidine derivative,as compared with gemcitabine,is non-inferior in terms of overall survival(OS)and is associated with lower hematologic toxicity.Accordingly,S-1 is a convenient oral alternative treatment for advanced PDAC.This study was aimed at comparing the efficacy and safety of gemcitabine plus S-1(GS)vs.GnP as first-line chemotherapy for advanced PDAC.Methods:Patients with advanced PDAC who received first-line GS or GnP at the Peking Union Medical College Hospital between March 2011 and November 2022 were evaluated.Results:A total of 300 patients were assessed,of whom 84 received GS and 216 received GnP.The chemotherapy completion rate was higher with GS than GnP(50.0%vs.30.3%,P=0.0028).The objective response rate(ORR)was slightly higher(14.3%vs.9.7%,P=0.35),and the median OS was significantly longer(17.9 months vs.13.3 months,P=0.0078),in the GS group than the GnP group.However,the median progression-free survival(PFS)did not significantly differ between groups.Leukopenia risk was significantly lower in the GS group than the GnP group(14.9%vs.28.1%,P=0.049).Conclusions:As first-line chemotherapy for advanced PDAC,the GS regimen led to a significantly longer OS than the GnP regimen.The PFS,ORR,and incidence of severe adverse events were comparable between the GS and GnP groups.
基金This research was supported by the Science Foundation of China University of Petroleum-Beijing(No.2462023QNXZ002)the National Key R&D Program of China(2021YFA1501201)+2 种基金the National Natural Science Foundation of China(No.22278174)Independent research project of State Key Laboratory of heavy oil(2021–01)Shandong Excellent Young Scientists Fund Program(Overseas,2022HWYQ-082).
文摘A novel composite material(TD)composed of TS-1 microcrystalline and dendritic mesoporous silica nanospheres(DMSNs)was successfully prepared.The TD composite material had open pore structure and large specific surface area,which was conducive to the mass transfer of reactants and products.The Ti element in TS-1 could be used as an electron assistant,and the spillover d-electrons were conducive to the improvement of the sulfidation and dispersion of MoS_(2),thereby forming more type II MoS_(2) active phases.The incorporation of Ti could bring more Brønsted(B)and Lewis(L)acid,which was conducive to the hydrogenation pathway(HYD)selectivity(41.2%)of dibenzothiophene(DBT)hydrodesulfurization(HDS)and isomerization(ISO)route selectivity(21.9%)of 4,6-dimethyldibenzothiophene(4,6-DMDBT)HDS,thus improve the HDS activity of DBT and 4,6-DMDBT.NiMo/TD-70(Aging temperature=70℃)had the best HDS activities of DBT(99.0%)and 4,6-DMDBT(93.7%)due to its large open pore structure,good acidity,suitable metal-support interaction(MSI)and perfect dispersion of the metallic active sites.
基金Supported by the National Basic Research Program of China （2009CB623406）, the National Natural Science Foundation of China （20806038）, the Natural Science Foundation of Jiangsu Province （BK2008504）, the National Science Foundation for Postdoctoral Scientists of China （20070421005） and Jiangsu Planned Projects for Postdoctoral Research Funds （0702020B）.
